Science Videos
from news services

Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial

Date:
August 21, 2012
Source:
MultiVu / Powered by NewsLook.com
Summary:
Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
Share:
         
Total shares:  
Related Videos
 

Share This Page:


Health & Medicine News
July 31, 2015

Latest Headlines
updated 12:56 pm ET